Terry C. Davis, Ph.D., a pioneer in the field of health literacy, is a professor of medicine and pediatrics at Louisiana State University Health Sciences Center in Shreveport. For the past 25 years, she has led an interdisciplinary team investigating the impact of patient literacy on health and health care. Seminal achievements include development of the Rapid Estimate of Adult Literacy in Medicine (REALM) and creation of user-friendly patient education and provider training materials that are being used nationally.
Dr. Davis has more than 120 publications related to health literacy and health communication. She has served on Health Literacy Advisory Boards for both the American Medical Association (AMA) and the American College of Physicians (ACP). She was an independent agent on the Institute of Medicine (IOM) Committee on Health Literacy and a developer of the AMA’s Train-the-Trainer Health Literacy Curriculum. Currently she is a member of the Healthy People 2020 Health Literacy/Health Communication Section and serves as a health literacy advisor to the U.S. Food and Drug Administration (FDA). She chaired Louisiana’s statewide Health Literacy Task Force, the first legislatively mandated health literacy group in the nation. She received the Louisiana Public Health Association’s Founders Award for Significant Achievement in Public Health Research. As a frequent speaker at national conferences, she has integrated her research findings into practical lessons for providers and policy makers.
Dr. Davis is the Health Literacy Principal Investigator (PI) on a National Institutes of Health (NIH) grant for the Louisiana Clinical and Translational Science Center, an unprecedented collaborative effort among eight academic institutions in Los Angeles. She is PI on a 5-year National
Cancer Institute health literacy intervention to increase regular breast and colorectal cancer (CRC) screening among patients in federally qualified health centers. Building on this work, she was recently awarded an American Cancer Society (ACS) grant to evaluate follow-up strategies to improve regular CRC screening in rural clinics in the state. Dr. Davis is also working with Drs. Mike Wolf and Ruth Parker on studies funded by the Agency for Healthcare Research and Quality to improve patient understanding and actual use of prescription medication labels in English and Spanish. Along with a team from the University of North Carolina and University of California, San Francisco, she has been funded by the ACP to develop and test practical self-management guides and videos for patients with diabetes, chronic obstructive pulmonary disease, coronary artery disease, obesity, and rheumatoid arthritis. ACP has distributed more than 5 million copies of these guides.
Victor J. Dzau, M.D., is the eighth President of the IOM. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Chairman of the Department of Medicine at Stanford University.
Dr. Dzau has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics, his pioneering of the discipline of vascular medicine, and his leadership in health care innovation. His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. Dr. Dzau also pioneered gene therapy for vascular disease, and his recent work on stem cell paracrine mechanisms and the use of microRNA in direct reprogramming provides novel insight into stem cell biology and regenerative medicine.
In his role as a leader in health care, Dr. Dzau has led efforts in health care innovation. His vision is for academic health sciences centers to lead the transformation of medicine through innovation, translation, and globalization. Leading this vision at Duke, he and his colleagues developed the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation. These initiatives create a seamless continuum from discovery and translational sciences to clinical care, and they promote transformative innovation in health.
As one of the world’s preeminent academic health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has
been a member of the Council of the IOM and the Advisory Committee to the Director of NIH, as well as Chair of NIH Cardiovascular Disease Advisory Committee and the Association of Academic Health Centers. He served on the Governing Board of the Duke-National University of Singapore Graduate Medical School and the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine. He also served as the Senior Health Policy Advisor to Her Highness Sheikha Moza (Chair of the Qatar Foundation). Currently, he is a member of the Board of Directors of the Singapore Health System, the Expert Board of the Imperial College Health Partners, United Kingdom, and the International Advisory Board of the Biomedical Science Council of Singapore. In 2011, he led a partnership between Duke University, the World Economic Forum, and McKinsey, and he founded the International Partnership for Innovative Healthcare Delivery and currently chairs its Board of Directors.
Among his honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine; the Max Delbruck Medal from Humboldt University, Charité, and the Max Planck Institute; the Commemorative Gold Medal from the Ludwig Maximilian University of Munich; the Inaugural Hatter Award from the Medical Research Council of South Africa; the Polzer Prize from the European Academy of Sciences and Arts; the Novartis Award for Hypertension Research; the Distinguished Scientist Award from the American Heart Association (AHA); and the AHA Research Achievement Award for his contributions to cardiovascular biology and medicine. Recently, he was awarded the Public Service Medal by the President of Singapore. He has received eight honorary doctorates.
Betsy L. Humphreys, M.L.S., is deputy director of the U.S. National Library of Medicine (NLM). As deputy director, she shares responsibility with the director for overall program development, program evaluation, policy formulation, direction, and coordination of all NLM activities. In addition, the deputy director is responsible for the day-to-day operations of NLM, and in the absence of the director, assumes full responsibility for all functions performed by NLM. Ms. Humphreys also coordinates the Unified Medical Language System (UMLS) project, which produces knowledge sources to support advanced retrieval and integration of information from disparate electronic information sources, and NLM’s activities related to health data standards. She contributes to the development of NIH and HHS policy on a range of matters, including health information technology, public access to research results, clinical trial registration and results reporting.
Ms. Humphreys received a B.A. from Smith College, where she was elected to Phi Beta Kappa, and an M.L.S. from the University of Maryland, College Park. She is a member of the IOM, a fellow of the American Col-
lege of Medical Informatics, and a fellow of the Medical Library Association. She has received a number of awards, including the Marcia C. Noyes Award, the Medical Library Association’s highest honor, the Morris F. Collen Award of Excellence from the American College of Medical Informatics, considered the highest honor in the field of medical informatics, and the rank of Meritorious Executive in the Senior Executive Service, conferred by the President of the United States.
George J. Isham, M.D., M.S., is Senior Advisor to HealthPartners, responsible for working with the board of directors and the senior management team on health and quality of care improvement for patients, members, and the community. Dr. Isham is also Senior Fellow, HealthPartners Institute for Education and Research, and facilitates progress at the intersection of population health, research, and public policy. Dr. Isham is active nationally and currently co-chairs the National Quality Forum convened Measurement Application Partnership, chairs the clinical program committee of the National Committee for Quality Assurances (NCQA), and is a member of NCQA’s committee on performance measurement. Dr. Isham is chair of the IOM’s Roundtable on Health Literacy and has chaired three studies in addition to serving on a number of IOM studies related to health and quality of care. In 2003 Isham was appointed as a lifetime National Associate of the National Academy of Sciences in recognition of his contributions to the work of the IOM. He is a former member of the Centers for Disease Control and Prevention’s (CDC’s) Task Force on Community Preventive Services and the Agency for Healthcare Research and Quality’s U.S. Preventive Services Task Force and currently serves on the advisory committee to the director of CDC. His practice experience as a general internist was with the U.S. Navy; at the Freeport Clinic in Freeport, Illinois; and as a clinical assistant professor of medicine at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin.
Howard K. Koh, M.D., M.P.H., is professor of the Practice of Public Health Leadership and director of the Leading Change Studio at the Harvard School of Public Health. From 2009 to 2014, Dr. Koh served as the 14th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS). He oversaw 12 core public health offices, including the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps, 10 Regional Health Offices across the nation, and 10 Presidential and Secretarial advisory committees. He also served as senior public health advisor to the Secretary. During his tenure, he championed the critical public health dimensions of the Affordable Care Act (ACA), promoted the enrollment of underserved populations into health insurance coverage, and was the primary architect of landmark HHS strategic plans
for tobacco control, health disparities, and chronic hepatitis. He also led interdisciplinary implementation of Healthy People 2020 and the National HIV/AIDS Strategy as well as initiatives in many other areas. Dr. Koh previously served at Harvard School of Public Health (2003-2009) as the Harvey V. Fineberg Professor of the Practice of Public Health, associate dean for Public Health Practice, and director of the Harvard School of Public Health Center for Public Health Preparedness. He has published more than 250 articles in the medical and public health literature.
Dr. Koh was Commissioner of Public Health for the Commonwealth of Massachusetts (1997-2003). As Commissioner, Dr. Koh led the Massachusetts Department of Public Health, which included a wide range of health services, four hospitals, and a staff of more than 3,000 professionals. He emphasized the power of prevention and strengthened the state’s commitment to eliminating health disparities. During his service, the state saw advances in areas such as tobacco control, cancer screening, bioterrorism response after 9/11 and anthrax, health issues of the homeless, newborn screening, organ donation, suicide prevention, and international public health partnerships.
Dr. Koh graduated from Yale College and Yale University School of Medicine. He completed postgraduate training at Boston City Hospital and Massachusetts General Hospital, serving as chief resident in both hospitals. He has earned board certification in four medical fields: internal medicine, hematology, medical oncology, and dermatology, as well as an M.P.H. from Boston University. At Boston University Schools of Medicine and Public Health, he was professor of dermatology, medicine, and public health as well as director of cancer prevention and control.
He has earned more than 70 awards and honors for interdisciplinary accomplishments in medicine and public health, including the Dr. Martin Luther King, Jr. Legacy Award for National Service, the Distinguished Service Award from ACS, and four honorary degrees. President Bill Clinton appointed Dr. Koh as a member of the National Cancer Advisory Board (2000-2002). He is an elected member of the IOM. A past chair of the Massachusetts Coalition for a Healthy Future (the group that pushed for the Commonwealth’s groundbreaking tobacco control initiative), Dr. Koh was named by the New England Division of ACS as “one of the most influential persons in the fight against tobacco during the past 25 years.” He has also received the 2012 Champion Award from the Campaign for Tobacco Free Kids, the “Hero of Epilepsy” Award from the Epilepsy Foundation and the Baruch S. Blumberg Prize from the Hepatitis B Foundation. He was named to the K100 (the 100 leading Korean Americans in the first century of Korean immigration to the United States) and has received the Boston University Distinguished Alumnus Award.
Gerald K. McEvoy, Pharm.D., is assistant vice president (AVP) of Drug Information at the American Society of Health-System Pharmacists (ASHP). In addition, Dr. McEvoy has served as editor-in-chief of AHFS Drug Information (AHFS DI) for more than 30 years. In his capacities as AVP of Drug Information and editor-in-chief of AHFS DI, AHFS Consumer Medication Information (AHFS CMI), and ASHP’s Handbook on Injectable Drugs, Dr. McEvoy is responsible for a variety of publishing and database management projects within ASHP focusing on dissemination of drug information in both electronic and print formats to various audiences, including health professionals and patients.
AHFS DI is designated an official compendium by the Centers for Medicare & Medicaid Services for establishing prescribing standards for medications based on accepted medical practice. AHFS CMI is the core medication information in the NLM’s publicly accessible MedlinePlus website and in its MedlinePlus Connect service for linking patient portals with electronic health records.
Dr. McEvoy has spoken widely on evidence-based development of drug prescribing information as well as on medication safety, best practices in prescription container labeling, and electronic data interchange through SGML and> Dr. McEvoy currently serves on the National Council on Patient Information and Education Board. He also served on the IOM Panel on Changing Prescription Medication Use Container Instructions to Improve Health Literacy and Medication Safety and subsequently was appointed co-chair of U.S. Pharmacopeia’s (USP’s) Health Literacy and Prescription Container Labeling Advisory Panel, which he continues to co-chair under its new name, Prescription Container Labeling Expert Panel. In addition, Dr. McEvoy is a recognized authority on consumer medication information, testifying before and advising FDA on medication safety communication issues involving consumers, advising Consumer Reports on medication use issues, being engaged for his expertise in this area by the Engelberg Center for Health Care Reform at The Brookings Institution, testifying before the Senate Special Committee on Aging, and speaking internationally on the provision of safe medication use information to consumers. His recognition also has resulted in appointment to additional IOM expert panels as part of workshops conducted by their Roundtable on Health Literacy and engagement in CDC to aid in development of the National Action Plan to Improve Health Literacy. Dr. McEvoy also is engaged in CDC’s PROTECT Initiative on medication safety.
Dr. McEvoy also participates in the development of medication data transfer standards through work with the National Council for Prescription Drug Programs (NCPDP). He currently serves as co-lead of NCPDP’s
SPL Activities Task Group, its SPL REMS Requirements Task Group, and its Naming Standards for Drugs, Biologics, and Biosimilars Task Group. Dr. McEvoy also is engaged in activities of the SPL Working Group (formed by the Pharmaceutical Research and Manufacturers of America’s HL7 Task Group), FDA’s Health and Regulatory Data Standards initiative, and NLM’s SPL/DailyMed initiatives. Through work with NCPDP, CDC, FDA’s Safe Use Initiative, and the American Pharmacists Association, he also has been instrumental in advancing national best practices aimed at avoiding inadvertent acetaminophen overdosage by patients and in advocating U.S. adoption of the mL as the standard unit for consumers to measure liquid oral medications. He recently completed his tenures on the BMJ Group North American Advisory Board and USP Safe Medication Use Expert Committee. Dr. McEvoy obtained both his baccalaureate and coctorate degrees in Pharmacy from Duquesne University and completed a hospital residency at Mercy Hospital in Pittsburgh. He recently was awarded the Duquesne University Pharmacy Alumni Achievement Award and inducted into the Cosmos Club for meritorious original work in science.
Theresa Michele, M.D., is the director of the Division of Nonprescription Drug Products (DNDP) in the Office of New Drugs, Center of Drug Evaluation and Research, at FDA. Previously the director of the Division of Nonprescription Clinical Evaluation (over-the-counter, or OTC, products regulated via the New Drug Application process), Dr. Michele oversaw the recent merger of that division with the Division of Nonprescription Regulation Development (OTC drugs regulated via the monograph process) to form DNDP. Prior to joining FDA, she spent 10 years in industry, with clinical research experience across a variety of therapeutic areas in both commercial and development-stage companies. Dr. Michele left industry in 2007 to join FDA in the Division of Pulmonary and Allergy Drug Products, where she served as a clinical reviewer and a team leader. She is board certified in internal medicine, pulmonary medicine, and critical care medicine, and completed her training at Johns Hopkins University. She obtained her B.S. in Integrated Life Sciences from Kent State University and her M.D. from Northeastern Ohio Universities College of Medicine as part of a 6-year combined program.
Michael Paasche-Orlow, M.D., M.A., M.P.H., is associate professor of medicine, Boston University School of Medicine. He is a general internist and a nationally recognized expert in the field of health literacy. Dr. Paasche-Orlow is currently a co-investigator with five funded grants that examine health literacy, including two intervention studies evaluating simplified information technologies for behavior change among minority patients with a range of health literacy levels. Dr. Paasche-Orlow’s work
has brought attention to the role health literacy plays in racial and ethnic disparities, self-care for patients with chronic diseases, end-of-life decision making, and the ethics of research with human subjects. Dr. Paasche-Orlow is the associate program director for the Boston University School of Medicine’s General Internal Medicine Academic Post-Doctoral Fellowship Program and the associate section chief for research for the Section of General Internal Medicine in the Boston University School of Medicine’s Department of Medicine.
Ruth Parker, M.D., is a Professor of Medicine and Public Health at Emory University School of Medicine. She developed one of the first measurement tools to quantify patients’ abilities to read and understand health information, the Test of Functional Health Literacy in Adults; co-wrote the definition of health literacy that is used by Healthy People, NIH, and the IOM report Health Literacy: A Prescription to End Confusion; and is the developer of a model of health literacy that is achieving growing recognition in the United States and internationally. Dr. Parker worked to define medication labels as an issue at the intersection of health literacy and patient safety, and she co-wrote the seminal white paper on the topic, which was presented to the IOM at a workshop on standardizing medication labels. This led to pivotal work by USP, where Dr. Parker worked on an expert panel to create standards for improved medication labels. This standard has now been published by USP.
Dr. Parker also works with FDA as a scientific expert Special Government Employee regarding medication labels and with the Nonprescription Drug Advisory Committee as an expert in consumer understanding of medication labels.
Dr. Parker is also a strong advocate for health literacy and its importance to health. She has worked tirelessly with professional societies, federal and state agencies, and congressional staff to inform them about health literacy issues and to encourage them to recognize health literacy as a priority issue.
Scott Ratzan, M.D., M.P.A., M.A., is vice president, global corporate affairs at Anheuser-Busch InBev. He has made major contributions to improve public health domestically and internationally. Dr. Ratzan is a pioneer in the areas of health literacy and mobile health (mHealth) communication. Additionally, he is the editor-in-chief of the peer-reviewed Journal of Health Communication: International Perspectives, serves as co-chair of the United Nations Secretary General’s Every Woman Every Child Innovation Working Group, serves on the World Economic Forum Global Agenda Council on Well-Being and Mental Health, and is a former Ambassador for global health research selected by Research!America. Dr. Ratzan main-
tains faculty appointments at the Columbia University Mailman School of Public Health, the Tufts University School of Medicine, and the George Washington University School of Public Health and Health Services. Prior to joining Anheuser-Busch InBev, Dr. Ratzan was vice president of global health at Johnson & Johnson, where he most recently was based in New Jersey, and previously was vice president of government affairs and policy based in Brussels, Belgium. Prior to joining Johnson & Johnson, he held positions in public health at the U.S. Agency for International Development and the Academy for Educational Development in Washington, DC, where he directed and developed a number of research and campaign activities for international institutions (including the World Health Organization) and the public and private sectors. He also spent a decade in Boston in academia as founder and director of the Emerson-Tufts Master’s Program in Health Communication. During that time he became editor-in-chief of the Journal of Health Communication, a monthly peer-reviewed publication.
Dr. Ratzan graduated from the University of Southern California with an M.D. in Medical Science, as well as an M.P.A. from the Kennedy School of Government at Harvard University and a master’s in Communication Studies from Emerson College. He has published several books and articles in the field of public health and he is a member of the Board of Scientific Counselors, Office of Infectious Diseases, CDC.
Lindsey Robinson, D.D.S., has maintained a full-time pediatric dental practice in Grass Valley for the past 16 years since receiving her certificate in pediatric dentistry from the University of Florida in 1995 and her D.D.S. degree from the University of Southern California in 1990. Dr. Robinson was a member of the ADA Council on Access, Prevention, and Interprofessional Relations for 6 years, and during her tenure served as Chair for 2 years. As CAPIR Chair she hosted two national access summits convened by the ADA, the American Indian/Alaska Native Oral Health Access Summit in 2007 and the Access to Care Summit in March 2009. She is a founding board member of the U.S. National Oral Health Alliance. Dr. Robinson currently serves as President-elect of the California Dental Association and is past Chair of the California Dental Association Foundation.
Russell Rothman, M.D., M.P.P., is an associate professor of internal medicine and pediatrics at Vanderbilt, and serves as director of the Vanderbilt Center for Health Services Research and chief of the Internal Medicine/ Pediatrics Section. Dr. Rothman received his bachelor’s and medical degrees from Duke University. During this time he also completed an M.P.P. at the Sanford Institute of Public Policy at Duke. After this, Dr. Rothman remained at Duke, where he completed a combined Internal Medicine and Pediatrics residency in 2000. From 2000 to 2002, he served as a Robert
Wood Johnson Foundation Clinical Scholar at the University of North Carolina at Chapel Hill. In 2002, he joined the faculty at Vanderbilt.
Dr. Rothman’s current research focuses on improving care for adult and pediatric patients with diabetes, obesity, and other chronic diseases. He has been funded by NIH, American Diabetes Association, and other sources to examine the role of literacy and numeracy in patients with diabetes and obesity. He has been PI on more than $20 million in extramural funding and has authored more than 90 manuscripts. He is currently PI on several NIH-funded studies addressing literacy and health communication in obesity prevention and diabetes. He is also PI of the Patient-Centered Outcomes Research Institute (PCORI) funded Mid-South Clinical Data Research Network, which engages more than 50 hospitals and thousands of ambulatory practices reaching patients across the nation. Dr. Rothman currently serves on the PCORI Health Disparities Advisory Board and the PCORnet Executive Steering Committee. He is also on the Board of Directors for the American Academy on Communication in Healthcare. Dr. Rothman has served as a reviewer on multiple NIH study sections, including the NIH Special Emphasis Panel on Health Literacy, and has been a Pfizer Visiting Professor in Health Literacy at several academic institutions. As director of the Vanderbilt Center for Health Services Research, Dr. Rothman oversees a center that engages more than 120 faculty across the university engaged in health services research, implementation science, behavioral research, health disparities research, quality improvement research, and other areas aimed at improving health outcomes.
Rima Rudd, Sc.D., M.S.P.H., is the Senior Lecturer on Health Literacy, Education, and Policy at the Harvard School of Public Health. Her work centers on health communication and on the design and evaluation of public health community-based programs. She has been teaching courses on innovative strategies in health education, program planning and evaluation, psychosocial and behavioral theory, and health literacy since 1988. Dr. Rudd is focusing her research inquiries and policy work on literacy-related disparities and literacy-related barriers to health programs, services, and care, working closely with the adult education, public health, oral health, and medical sectors.
Dr. Rudd wrote several reports that help shape the agenda in health literacy research and practice. They include the health literacy chapter of the Health and Human Services report Communicating Health: Priorities and Strategies for Progress (2003) and helped shape the 2010 National Call for Action. She coded all health related items in the international surveys for assessments of adult literacy skills enabling the United States, Canada, Australia, New Zealand, and other countries to assess national health literacy skills. She authored the Educational Testing Services report Literacy
and Health in America (2004) and contributed to other national assessments. Dr. Rudd provided two in-depth literature reviews (Review of Adult Learning and Literacy volume 1 in 2000 and volume 7 in 2007). She served on the IOM Committee on Health Literacy, the National Research Council Committee on Measuring Adult Literacy, the National Institute of Dental and Craniofacial Research Workgroup on Oral Health Literacy, on the Joint Commission Advisory Committee on Health Literacy and Patient Safety and contributed to the ensuing reports and white papers as well as to several IOM Health Literacy Round Table publications. She has received national and international awards for her work in health literacy. Most recently, the University of Maryland named a doctoral scholar’s award in her honor.
Barbara L. Schuster, M.D., MACP, is Campus Dean, Georgia Regents University/University of Georgia Medical Partnership. Previously, she was a professor of internal medicine at Wright State University and the former chair of the Department of Internal Medicine for nearly 12 years. During the 2007-2008 academic year, she was a Robert G. Petersdorf Scholar-in-Residence at the Association of American Medical Colleges (AAMC). Before accepting the chair position at Wright State University, Dr. Schuster was program director of the Primary Care Program in Internal Medicine and the combined Internal Medicine/Pediatrics Program in Rochester, New York. She completed an undergraduate degree in Biology and a master’s of Science in Education at the University of Pennsylvania. She received her M.D. from the University of Rochester and completed her residency in the Associated Hospitals Program in Rochester.
Dr. Schuster is a past president of the Association of Professors of Medicine and served on the Board of the Alliance for Academic Internal Medicine. She is also a former president of the Association of Program Directors in Internal Medicine. She served as the chair of the Council of Academic Societies of AAMC in 2003-2004 and served 6 years on the Executive Council of AAMC. Dr. Schuster also has been actively involved in ACP. As a Regent, she served on the Recertification Committee and the Nominations Committee. She chaired the Awards Committee, ACP Education Committee, and ACP Foundation Board of Trustees. She was honored with Mastership in ACP in 1996.
Steven M. Teutsch, M.D., M.P.H., was formerly the chief science officer of Los Angeles County Public Health, where he worked on evidence-based public health and policy. He had been in the Outcomes Research and Management program at Merck, where he was responsible for scientific leadership in developing evidence-based clinical management programs, conducting outcomes research studies, and improving outcomes measurement to enhance quality of care. Prior to joining Merck, he was director
of the Division of Prevention Research and Analytic Methods (DPRAM) at CDC, where he was responsible for assessing the effectiveness, safety, and cost-effectiveness of disease and injury prevention strategies. DPRAM developed comparable methodology for studies of the effectiveness and economic impact of prevention programs, provided training in these methods, developed CDC’s capacity for conducting necessary studies, and provided technical assistance for conducting economic and decision analysis. The Division also evaluated the impact of interventions in urban areas, developed the Guide to Community Preventive Services, and provided support for CDC’s analytic methods. He has served as a member of that Task Force and the U.S. Preventive Services Task Force, which develops the Guide to Clinical Preventive Services. He was also in America’s Health Information Community Personalized Health Care Workgroup and the Evaluation of Genomic Applications in Prevention and Practice (EGAPP) Workgroup. He chaired the Secretary’s Advisory Committee on Genetics Health and Society; served on and has chaired IOM panels, Medicare’s Evidence Development and Coverage Advisory Committee, and several subcommittees of the Secretary’s Advisory Committee on Healthy People 2020. He has been on multiple IOM panels.
Dr. Teutsch came to CDC in 1977, where he was assigned to the Parasitic Diseases Division and worked extensively on toxoplasmosis. He was then assigned to the Kidney Donor and subsequently the Kidney Disease Program. He developed the framework for CDC’s diabetes control program. He joined the Epidemiology Program Office and became director of the Division of Surveillance and Epidemiology, where he was responsible for coordinating CDC’s disease monitoring activities. He became chief of Prevention Effectiveness Activity in 1992.
Dr. Teutsch received his undergraduate degree in biochemical sciences at Harvard University, an M.P.H. in Epidemiology from the University of North Carolina School of Public Health, and his M.D. from Duke University School of Medicine. He completed his residency training in Internal Medicine at Pennsylvania State University, Hershey. He has been certified by the American Board of Internal Medicine and the American Board of Preventive Medicine, and is a Fellow of the American College of Physicians and American College of Preventive Medicine. Dr. Teutsch is an adjunct professor at the Emory University School of Public Health, Department of Health Policy and Management; University of North Carolina School of Public Health; adjunct professor at the University of California, Los Angeles, School of Public Health; and Senior Scholar at the Schaeffer Center at the University of Southern California.
Dr. Teutsch has published more than 200 articles and 8 books in a broad range of fields in epidemiology, including parasitic diseases, diabetes, technology assessment, health services research, and surveillance.
Michael S. Wolf, M.A., M.P.H., Ph.D., is professor of medicine, associate division chief (Internal Medicine & Geriatrics), and director of the Health Literacy & Learning Program within the Feinberg School of Medicine, Northwestern University. He also holds appointments in Cognitive Sciences, Communication Studies, Medical Social Sciences, Psychiatry & Behavioral Sciences, and Surgery. As a health services researcher and cognitive-behavioral scientist, Dr. Wolf has extensively studied cognitive, psychosocial, and health-system determinants of health, specifically in the area of health literacy and health communications research. His work has primarily focused on understanding health care complexity; Dr. Wolf has led several large-scale, pragmatic trials to evaluate multifaceted interventions to promote patient engagement in health, targeting chronic disease self-management, medication safety, and adherence.
Winston F. Wong, M.D., M.S., serves as Medical Director, Community Benefit, Kaiser Permanente, and is responsible for the organization’s partnerships with communities and institutions in advancing population management and evidence based medicine, with a particular emphasis on safety net providers and the elimination of health disparities. As a Captain of the Commissioned Corp of the U.S. Public Health Service from 1993 to 2003, Dr. Wong was awarded the Outstanding Service Medal. Wong currently has served on a number of national advisory committees, including those sponsored by the National Quality Forum, Centers for Medicare & Medicaid Services, and the IOM, addressing issues of access and quality for diverse populations, most recently as a member of the IOM Committee on the Integration of Primary Care and Public Health. In 2013, Dr. Wong was appointed to the IOM’s Board on Population Health and Public Health Practice. He is also a Board member of The California Endowment, the Essential Hospitals Institute, and the School Based Health Alliance. Bilingual in Cantonese and Toisan dialects, and a graduate of the University of California, Berkeley, and the University of California, San Francisco, School of Medicine, Dr. Wong continues a small practice in Family Medicine at Asian Health Services, a federally qualified health center based in Oakland, where he previously served as Medical Director. Dr. Wong was featured as a “Face of Public Health” in the May 2010 issue of the American Journal of Public Health.
Victor Yung-Tao Wu, M.D., M.P.H., is the managing director for clinical transformation at Evolent Health, a Population Health Services organization. Before joining Evolent, he served as a 2013-2014 White House Fellow in the HHS Office of the Secretary. He was involved in the ACA outreach and enrollment and worked on the President’s My Brother’s Keeper initiative, among other projects, during his time as a Fellow. Dr. Wu completed
his medical school, public health, and residency training in Primary Care Internal Medicine at Emory University. He also served as chief medical resident at Grady Memorial Hospital, during which time he collaborated with the IOM Roundtable on Health Literacy to develop a Health Insurance Literacy toolkit and consumer education series around the basics of health insurance. His completed his undergraduate studies at Vanderbilt University in Biomedical Engineering.